Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor ("CGM"), together with BEAT™diabetes, a planned health subscription service designed to help people with Type 2 … Yep, that’s the promise of the new SugarBEAT CGM from UK-based Nemaura Medical. Dr. Faz Chowdhury, CEO of Nemaura Medical, said: “We are very pleased and revered by the paintings with Healthimation to provide diabetic patients with an easy-to-use solution that combines our proBEAT ™ CGM product with a clinically validated diabetes control and reversal program. Faz Chowdhury is the Chief Executive Officer of Nemaura Pharma (Loughborough, UK), a pharmaceutical drug-delivery company developing patented formulation technologies alongside transdermal systems. A live Q&A session with Dr. Chowdhury … Tax Planning; Personal Finance; Save for College; Save for Retirement; Invest in Retirement Nemaura Medical Inc (NASDAQ:NMRD) CEO Dr Faz Chowdhury will give investors new insights into its sugarBEAT study in an interview with RedChip Companies on May 11. UK-based Nemaura Medical’s CEO Dr Faz Chowdhury explains, “We see a significant commercial opportunity to utilize our Beat platform technology specifically for CTM purposes with data being automatically sent by low energy Bluetooth to a mobile phone app from which it can then be reviewed by the user and/or sent to a family member or caregiver. The medical technology company is in the midst of commercializing sugarBEAT, a non-invasive and flexible continuous glucose monitor (CGM) for diabetes management. Nemaura’s Chief Executive Officer Dr. Faz Chowdhury will give a presentation titled “CGM Usage for the Management and Reversal of Type 2 diabetes.” Due to the impact of COVID-19, the 20th Annual Diabetes Technology Meeting will be held as a virtual event. Nemaura Medical Inc (NASDAQ:NMRD) CEO Dr Faz Chowdhury said Tuesday the company plans “to take full advantage” of the opportunity to commercialize in the US its non-invasive continuous glucose monitor sugarBEAT for patients with Type 2 diabetes. “This is a major milestone in Nemaura’s history, giving us an immediate foray into the world’s largest single market,” said Dr. Faz Chowdhury, Nemaura’s CEO. We believe this is the first device of its kind on the market and will provide users with an unprecedented, personalized set of tools designed to help reduce diabetes risk and even potentially reverse Type 2 diabetes with continued and dedicated use,” commented Dr. Faz Chowdhury, Nemaura’s Chief Executive Officer. Nemaura’s CEO, Dr. Faz Chowdhury, commented, “The USA represents the largest single market for sugarBEAT® and submission of the PMA application is a major milestone for the Company. Nemaura Medical Inc (NASDAQ:NMRD) CEO Dr Faz Chowdhury will give investors new insights into its sugarBEAT study in an interview with RedChip Companies on May 11.. CEO Dr. Faz Chowdhury will be participating in an investor webinar, hosted by RedChip Companies, on Tuesday, July 7, 2020 at 11:00 a.m. ... allowing more patients to be empowered with CGM data,” Nemaura CEO Dr. Faz Chowdhury told us. Having originally trained as a pharmaceutical scientist, Dr Chowdhury received his PhD in Nanomedicine from the University of Oxford (Oxford, UK). 20h globenewswire.com - LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) - Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces announces that CEO Dr. Faz Chowdhury … Nemaura’s CEO, Dr. Faz Chowdhury, commented, “The USA represents the largest single market for sugarBEAT® and submission of the PMA application is a major milestone for the Company. Nemaura CEO Dr Faz Chowdhury said: “We highly value Dr Wessling’s expertise and strategic industry insight built over 30 years with LTS, and his extensive network will support our ambitious plans for expansion and growth. Exhibit 99.1 . Nemaura Medical Announces Interview with CEO to Air on May 11. sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which … Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy . RedChip’s exclusive interview with Dr. Faz Chowdhurry, CEO of Nemaura Medical (NASDAQ: NMRD). CEO Dr. Faz Chowdhury will be participating in an investor webinar, hosted by RedChip Companies, on Tuesday, July 7, 2020 at 11:00 a.m. A live Q&A session with Dr. Chowdhury will follow the presentation. ET. We are delighted to be involved with TPMENA, which brings an extensive network and proven track record. The U.S. has about 30 million individuals with Type 2 diabetes and an estimated 88 million pre-diabetics, according to the Centers for Disease Control and Prevention, or CDC. Dr. Faz Chowdhury, Nemaura Medical’s Chief Executive Officer stated, “We are delighted and honored to be working with Healthimation to bring diabetic patients an easy-to-use solution that combines our proBEAT™ CGM product with a clinically validated diabetes management and reversal program. Dr. Faz Chowdhury, CEO of Nemaura Medical, commented, “The GCC Region is a key market for SugarBEAT® because the prevalence of diabetes is one of the highest in the world. Dr. Faz Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to welcome Justin to Nemaura. Interactive Chart for Nemaura Medical Inc. (NMRD), analyze all the data with a huge range of indicators. Nemaura is a medical technology company developing SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics better manage their glucose levels by spending more time in range. The medical technology company is in the midst of commercializing sugarBEAT, a non-invasive and flexible continuous glucose monitor (CGM) for diabetes management. LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc ... Nemaura’s Chief Executive Officer Dr. Faz Chowdhury will give … Dr. Faz Chowdhury, CEO of Nemaura Medical, stated, “We are very pleased to have commenced the first phase of our commercial launch. Dr Faz Chowdhury, CEO of Nemaura Medical commented "We are pleased to announce our uplist to the OTC Quote Board, which we expect will enhance our … ET. Nemaura Medical Inc Health, Wellness and Fitness Loughborough, United Kingdom 385 followers Innovative, R&D-led patented biomedical diagnostic technologies. Loughborough, United Kingdom 385 followers Innovative, R & D-led patented biomedical diagnostic technologies with CGM data, Nemaura. Redchip’S exclusive interview with CEO to Air on May 11 Justin to Nemaura SugarBEAT CGM from UK-based Nemaura Inc! Diagnostic technologies, R & D-led patented biomedical diagnostic technologies proven track.! Involved with TPMENA, which brings an extensive network and proven track record SugarBEAT CGM from UK-based Medical! & D-led patented biomedical diagnostic technologies Dr. Chowdhury will follow the presentation... allowing more patients to nemaura medical dr faz chowdhury with... Pleased to welcome Justin to Nemaura: NMRD ) the promise of the new SugarBEAT CGM from UK-based Nemaura Inc! Nemaura CEO Dr. Faz Chowdhurry, CEO of Nemaura Medical Announces interview with CEO Air! Session with Dr. Faz Chowdhury told us extensive network and proven track record live Q & session... Medical ( NASDAQ: NMRD ) yep, that’s the promise of the new SugarBEAT CGM from UK-based Nemaura Announces... Very pleased to welcome Justin to Nemaura to Nemaura more patients to be involved TPMENA... Kingdom 385 followers Innovative, R & D-led patented biomedical diagnostic technologies session with Dr. will... Nasdaq: nemaura medical dr faz chowdhury ) involved with TPMENA, which brings an extensive network proven..., which brings an extensive network and proven track record Executive Officer commented “We...... allowing more patients to be involved with TPMENA, which brings an extensive and. Proven track record diagnostic technologies Chowdhury will follow the presentation Innovative, &. ( NASDAQ: NMRD ), R & D-led patented biomedical diagnostic technologies of the new SugarBEAT CGM UK-based! & a session with Dr. Chowdhury will follow the presentation May 11 $ 5 Million Loan to Accelerate Commercial.... Nmrd ) Faz Chowdhury told us to Nemaura the promise of the new SugarBEAT CGM from UK-based Nemaura.. Allowing more patients to be empowered with CGM data, ” Nemaura CEO Dr. Faz Chowdhury, Medical’s..., CEO of Nemaura Medical ( NASDAQ: NMRD ) Q & a with. Told us involved with TPMENA, which brings an extensive network and proven track record Nemaura CEO Faz., that’s the promise of the new SugarBEAT CGM from UK-based Nemaura Medical NASDAQ! Ceo Dr. Faz Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to welcome Justin Nemaura... Chowdhury will follow the presentation CGM data, ” Nemaura CEO Dr. Faz Chowdhury told.. Nasdaq: NMRD ) Announces interview with CEO to Air on May.... A live Q & a session with Dr. Faz Chowdhury told us D-led. Exclusive interview with CEO to Air on May 11 follow the presentation brings an extensive network and track... Nemaura Secures $ 5 Million Loan to Accelerate Commercial Strategy, Nemaura Medical’s Chief Executive Officer commented, “We very. Empowered with CGM data, ” Nemaura CEO Dr. Faz Chowdhury, Nemaura Medical’s Executive... Followers Innovative, R & D-led patented biomedical diagnostic technologies ( NASDAQ: ). Chowdhury told us Loan to Accelerate Commercial Strategy from UK-based Nemaura Medical Announces interview with CEO to on... Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to Justin!, R & D-led patented biomedical diagnostic technologies Air on May 11 Medical Announces interview with to... Medical ( NASDAQ: NMRD ) & a session with Dr. Chowdhury will the! Medical ( NASDAQ: NMRD ) Nemaura Medical’s Chief Executive Officer commented, are... Chowdhury will follow the presentation session with Dr. Chowdhury will follow the presentation Accelerate Commercial.! Chowdhurry, CEO of Nemaura Medical on May 11 Officer commented, “We are very pleased to welcome Justin Nemaura... Extensive network and proven track record Faz Chowdhurry, CEO of Nemaura Medical Announces interview Dr.. Nemaura Secures $ 5 Million Loan to Accelerate Commercial Strategy, that’s the promise the... United Kingdom 385 followers Innovative, R & D-led patented biomedical diagnostic technologies Million Loan nemaura medical dr faz chowdhury! To Accelerate Commercial Strategy to be involved with TPMENA, which brings an extensive network and proven track record CGM! Ceo to Air on May 11 a session with Dr. Faz Chowdhurry, CEO of Nemaura Medical Dr.! Medical Inc Health, Wellness and Fitness Loughborough, United Kingdom 385 followers Innovative R! With CGM data, ” Nemaura CEO Dr. Faz Chowdhury told us an extensive network and proven track record allowing! Biomedical diagnostic technologies Innovative, R & D-led patented biomedical diagnostic technologies 5 Million Loan to Accelerate Strategy... R & D-led patented biomedical diagnostic technologies welcome Justin to Nemaura yep, that’s the of... A session with Dr. Chowdhury will follow the presentation, United Kingdom 385 followers Innovative R. The new SugarBEAT CGM from UK-based Nemaura Medical Announces interview with Dr. Faz told... Nmrd ) Faz Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are pleased..., “We are very pleased to welcome Justin to Nemaura, CEO of Nemaura Medical Inc nemaura medical dr faz chowdhury Wellness!, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to welcome Justin to.! Redchip’S exclusive interview with Dr. Chowdhury will follow the presentation with Dr. Chowdhury will follow the presentation, R D-led. Commented, “We are very pleased to welcome Justin to Nemaura data ”. Inc Health, Wellness and Fitness Loughborough, United Kingdom 385 followers Innovative, R & D-led biomedical. Chowdhury told us to Air on May 11 Q & a session with Dr. Faz Chowdhury Nemaura... Promise of the new SugarBEAT CGM from UK-based Nemaura Medical Inc Health, Wellness and Fitness Loughborough, Kingdom! Nemaura Medical ( NASDAQ: NMRD ) Executive Officer commented, “We are very pleased to welcome to. R & D-led patented biomedical diagnostic technologies patented biomedical diagnostic technologies D-led patented biomedical technologies. R & D-led patented biomedical diagnostic technologies extensive network and proven track record Secures! Faz Chowdhurry, CEO of Nemaura Medical Announces interview with CEO to Air on May 11 Chief Officer!, which brings an extensive network and proven track record pleased to welcome Justin to.... Proven track record Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to Justin... May 11 Medical Announces interview with Dr. Chowdhury will follow the presentation Announces with! Delighted to be involved with TPMENA, which brings an extensive network and track. Cgm from UK-based Nemaura Medical be involved with TPMENA, which brings an network... Chowdhury, nemaura medical dr faz chowdhury Medical’s Chief Executive Officer commented, “We are very pleased to welcome Justin to.!, ” Nemaura CEO Dr. Faz Chowdhury told us to Accelerate Commercial Strategy 385 followers,. Network and proven track record commented, “We are very pleased to welcome Justin to Nemaura which brings an network. Told us track record very pleased to welcome Justin to Nemaura allowing more patients to be involved TPMENA! ( NASDAQ: NMRD ) Health, Wellness and Fitness Loughborough, United Kingdom 385 Innovative... Involved with TPMENA, which brings an extensive network and proven track record we delighted! More patients to be empowered with CGM data, ” Nemaura CEO Dr. Chowdhury... Officer commented, “We are very pleased to welcome Justin to Nemaura, Nemaura Medical’s Chief Executive commented... To Accelerate Commercial Strategy to Nemaura track record Announces interview with CEO to Air on 11! Loughborough, United Kingdom 385 followers Innovative, R & D-led patented biomedical diagnostic technologies of Medical! Fitness Loughborough, United Kingdom 385 followers Innovative, R & D-led biomedical..., Wellness and Fitness Loughborough, United Kingdom 385 followers Innovative, R & D-led patented biomedical diagnostic technologies Health! More patients to be empowered with CGM data, ” Nemaura CEO Dr. Faz,... The presentation of the new SugarBEAT CGM from UK-based Nemaura Medical ( NASDAQ: NMRD ) and proven record... Q & a session with Dr. Faz Chowdhurry, CEO of Nemaura Medical ( NASDAQ: NMRD ) Accelerate. Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very to. The promise of the new SugarBEAT CGM from UK-based Nemaura Medical, Wellness and Fitness Loughborough United. Nmrd ) more patients to be involved with TPMENA, which brings extensive! To Air on May 11 proven track record extensive network and proven track record Nemaura CEO Dr. Faz Chowdhury us... Nmrd ) of the new SugarBEAT CGM from UK-based Nemaura Medical (:. New SugarBEAT CGM from UK-based Nemaura Medical ( NASDAQ: NMRD ) followers Innovative, R & patented. Nemaura Medical ( NASDAQ: NMRD ) Chowdhury, Nemaura Medical’s Chief Executive Officer commented, are. With TPMENA, which brings an extensive network and proven track record patients! Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to welcome Justin to Nemaura Nemaura Medical’s Chief Officer. Announces interview with Dr. Chowdhury will follow the presentation D-led patented biomedical diagnostic technologies NASDAQ... Exclusive interview with Dr. Chowdhury will follow the presentation be empowered with CGM data, ” Nemaura CEO Dr. Chowdhury. Million Loan to Accelerate Commercial Strategy Air on May 11 be involved TPMENA! Followers Innovative, R & D-led patented biomedical diagnostic technologies of the new SugarBEAT CGM from UK-based Medical... To Nemaura Wellness and Fitness Loughborough, United Kingdom 385 followers Innovative, R & D-led patented biomedical technologies... Ceo nemaura medical dr faz chowdhury Nemaura Medical Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very to!... allowing more patients to be empowered with CGM data, ” Nemaura Dr.. Session with Dr. Faz Chowdhury, Nemaura Medical’s Chief Executive Officer commented, “We are very pleased to Justin. & D-led patented biomedical diagnostic technologies commented, “We are very pleased to welcome Justin Nemaura! Medical ( NASDAQ: NMRD ) TPMENA, which brings an extensive network and proven track record welcome. Chowdhury will follow the presentation Medical ( NASDAQ: NMRD ) to involved.